Global Tissue Engineering Market by Application (Musculoskeletal, Dental, GI & Gynecology, & Spine, Cancer, Orthopedics, Cord Blood & Cell Banking) and Region (North America, Latin America, Europe, Asia Pacific and Middle East & Africa), Forecast To 2028

Summary of the Report

Global tissue engineering market was valued at USD 9.9 Billion in 2019. It is projected to grow by 14.2% between 2020 and 2027. Tissue engineering techniques have the potential to treat irreversible tissue damage. This has driven market growth. This growth is further supported by a rising demand for Regenerative medicine as well as tissue engineering procedures to repair damaged tissues.

Tissue engineering offers alternatives to surgery, transplants, or other mechanical devices. It is used to repair damaged tissue. Tissue engineering is also driven largely by an increase in the demand for effective regenerative therapies due to an increase in diabetes, obesity, and other diseases, as well as a growing number of trauma cases and lifestyle changes.

Technology advancements in 3D tissue engineering such as the replacement of embryo cells by stem cells, organ on a chip technology and the use of 3D bioprinters to efficiently design in vitro implant designs are expected to increase growth. The market for tissue engineering will grow if there is an increase in funding from the government for academic and medical research.

According to the National Institutes of Health's April 2019 publication, funding for different research, condition and disease categories (RCDC), funding for stem cell research (and regenerative medicine) was USD 1.8 billion and USD 1.0 million respectively in 2018. These two areas are estimated to receive funding from the NIH in 2020 at USD 1.7 billion and USD 915 millions, respectively.

Stem cell therapies are promising therapeutic options for a variety of clinical conditions. These investments have resulted in significant global investment in clinical translation and research. Stem cell research has made rapid advances that have helped improve disease management. With an increase in cancer and diabetes incidences, research on stem cell has increased.

Researchers are working to reprogram stem cells to create artificial organs or restore normal function. The tissue engineering market will benefit from stem cells' use in many applications. Advanced reprogramming technologies that use stem cells will replace artificial pacemakers, for example.

Application Insights

Due to an increase in the number of musculoskeletal conditions, the spine segment, orthopedics, and musculoskeletal dominated the tissue engineering market in 2019. The orthopedic regenerative segment comprises the spine, bone substitutes and bone grafts. According to the U.S. Medicare facility and Medicaid facility, around 900,000.000 surgeries each year require bone reconstruction or replacement. Due to nearly 15 million cases of fracture each year, the healthcare burden in the U.S. has risen by USD 60 billion.

Histogenics Corp., MiMedix Group, Inc., Genzyme, and DiscGenics all have products in their pipeline that have shown positive results in preclinical trials . These products are expected to be successful in the forecast period. This will contribute significantly to segment growth.

Due to the rapid rise in cardiovascular diseases worldwide, the cardiology and the vascular segments are predicted to have the highest growth rates in the market for tissue engineering during the analysis period. Key players are also involved in stem cell therapies that repair, restore and revascularize damaged heart tissue. To stimulate the regeneration and repair of damaged heart cells, advanced biologics and small molecules are also being investigated.

In order to understand the effects of cardiovascular diseases, single and mixed cells from allogeneic and autologous stem cells are being adopted more often. Segment growth will be boosted by technological advances in tissue engineering technology. The future growth potential for tissue engineering is possible with the development of 3D Engineered Heart Tissue and 3D Heart Muscles.

Regional Insights

North America had the highest revenue share in 2019, due to an increase in awareness of stem cell therapy and a growing number of elderly people. A growing market for tissue engineering is also possible due to the availability of funding from both private and public sources, as well as advanced technology in diagnosing and treating chronic diseases.

Due to both the availability of funds from government and high private investment, the U.S. accounts for a significant share of revenue. To bring stem cell therapy and regenerative medicine to the forefront of healthcare, the U.S. Department of Health created the "2020: A New Vision" initiative. Regenerative medicine has a transformative effect on clinical practice. This is a critical aspect of technological innovation and translation.

Asia Pacific is predicted to experience the fastest growth rate during the forecast period. Japan is a country that has made great strides in tissue engineering technology. The market for tissue engineering is expected to grow in Asia due to an increase in cancer and other clinical conditions. Market growth is also driven by factors such as 3D bioprinting's development and medical tourism.

Japan is a desirable outsourcing market for tissue engineering in developed countries like the U.S. The Regenerative Medicine Law, approved by the Ministry of Health, Labor, and Welfare, allows for the adoption of procedures that could accelerate the clinical development of cell-based and regenerative therapies.

Market Share in Tissue Engineering

Medtronic plc, Zimmer Biomet Holdings, Inc, Allergan plc, Athersys, Inc, ACell, Inc., Organogenesis Holdings Inc., Tissue Regenix Group plc, Stryker Corporation, RTI Surgical, Inc., Integra LifeSciences Corporation, ReproCell, Inc., and Baxter International, Inc. are key players in the tissue engineering market.

To gain an edge over their competition, key players are entering into partnerships and agreements. ACell and MyungMoon Bio Co. Ltd. signed an exclusive distribution agreement in March 2019 for ACell's Cytal Wound Matrix, and MicroMatrix wound management products in South Korea. MyungMoon is a well-respected distributor and manufacturer of medical devices and drugs in South Korea.

Other than this, the key players are involved in developing novel tissue engineering products as well as upgrading their product portfolios to keep up with current demand. ACell was granted additional FDA approval in April 2019 for its Gentrix product lines. This resulted in a rise in the number of patients who can use Gentrix's surgical matrix products.

The Report Covers Certain Segments

This report provides forecasts for revenue growth at the global, regional and country level and analyzes the most recent industry trends in each sub-segment from 2016-2027. Grand View Research analyzed the global tissue engineering market report by region and application.

• App Outlook (Revenue USD Million, 2016-2027)

  • Cord blood & Cell Banking

  • Cancer

  • GI, Gynecology

  • Dental

  • Skin and Integumentary

  • Urology

  • Orthopedics, Musculoskeletal and Spine

  • Neurology

  • Cardiology & Vascular

  • Other

• Regional Outlook (Revenue USD Million, 2016-2027)

  • North America

    • The U.S.

    • Canada

  • Europe

    • Germany

    • France

    • The U.K.

  • Asia Pacific

    • Japan

    • China

    • India

  • Latin America

    • Brazil

    • Mexico

  • MEA

    • South Africa

These are the most frequently asked questions about this report

b. Global tissue engineering market size was USD 9.99 billion in 2019, and is forecast to grow to USD 11.4 billion by 2020.

b. Global tissue engineering market will grow at a compound annual rate of 14.2% between 2020 and 2027, reaching USD 28.9 million by 2027.

b. With a 52.4% share in 2019, North America was the dominant market for tissue engineering. This can be attributed to the increasing awareness of stem cell therapy and the growing geriatric population.

b. Medtronic plc, Zimmer Biomet Holdings, Inc, Allergan plc, Athersys, Inc, ACell, Inc., Organogenesis Holdings Inc., Tissue Regenix Group plc, Stryker Corporation, RTI Surgical, Inc., Integra LifeSciences Corporation, ReproCell, Inc., and Baxter International, Inc. are some of the key players in the tissue engineering market.

b. The market is driven by advances in stem cell technology and tissue engineering, an increase in clinical studies for regenerative medicine, and increased funding for tissue engineering research.

Up Market Research published a new report titled “Tissue Engineering Market research report which is segmented by Application (Musculoskeletal, Dental, GI & Gynecology, & Spine, Cancer, Orthopedics, Cord Blood & Cell Banking), By Players/Companies Inc; Integra LifeSciences Corporation; ReproCell, Medtronic plc; Zimmer Biomet Holdings, Inc; Organogenesis Holdings Inc; Tissue Regenix Group plc; Stryker Corporation; RTI Surgical, Inc; ACell, Inc; and Baxter International, Inc, Inc; Allergan plc; Athersys”. As per the study the market is expected to grow at a CAGR of XX% in the forecast period.

Report Scope

The report covers comprehensive data on emerging trends, market drivers, growth opportunities, and restraints that can change the market dynamics of the industry. It provides an in-depth analysis of the market segments which include products, applications, and competitor analysis.

Global Tissue Engineering Market Report Segments:

The market is segmented by Application (Musculoskeletal, Dental, GI & Gynecology, & Spine, Cancer, Orthopedics, Cord Blood & Cell Banking).

Tissue Engineering Market research report delivers a close watch on leading competitors with strategic analysis, micro and macro market trend and scenarios, pricing analysis and a holistic overview of the market situations in the forecast period. It is a professional and a detailed report focusing on primary and secondary drivers, market share, leading segments and geographical analysis. Further, key players, major collaborations, merger & acquisitions along with trending innovation and business policies are reviewed in the report.

Key Benefits for Industry Participants & Stakeholders:

• Industry drivers, restraints, and opportunities covered in the study
• Neutral perspective on the market performance
• Recent industry trends and developments
• Competitive landscape & strategies of key players
• Potential & niche segments and regions exhibiting promising growth covered
• Historical, current, and projected market size, in terms of value
• In-depth analysis of the Tissue Engineering Market

Overview of the regional outlook of the Tissue Engineering Market:

Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa (MEA). North America region is further bifurcated into countries such as U.S., and Canada. The Europe region is further categorized into U.K., France, Germany, Italy, Spain, Russia, and Rest of Europe. Asia Pacific is further segmented into China, Japan, South Korea, India, Australia, South East Asia, and Rest of Asia Pacific. Latin America region is further segmented into Brazil, Mexico, and Rest of Latin America, and the MEA region is further divided into GCC, Turkey, South Africa, and Rest of MEA.

Highlights of The Tissue Engineering Market Report:

1. The market structure and projections for the coming years.
2. Drivers, restraints, opportunities, and current trends of Tissue Engineering Market.
3. Historical data and forecast.
4. Estimations for the forecast period 2028.
5. Developments and trends in the market.

                1. Musculoskeletal

                2. Dental

                3. GI & Gynecology

                4. & Spine

                5. Cancer

                6. Orthopedics

                7. Cord Blood & Cell Banking

7. Market scenario by region, sub-region, and country.
8. Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
9. Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
10. Government Policies, Macro & Micro economic factors are also included in the report.

We have studied the Tissue Engineering Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2028.

How you may use our products:

• Correctly Positioning New Products
• Market Entry Strategies
• Business Expansion Strategies
• Consumer Insights
• Understanding Competition Scenario
• Product & Brand Management
• Channel & Customer Management
• Identifying Appropriate Advertising Appeals

Reasons to Purchase the Tissue Engineering Market Report:

• The report includes a plethora of information such as market dynamics scenario and opportunities during the forecast period
• Segments and sub-segments include quantitative, qualitative, value (USD Million,) and volume (Units Million) data.
• Regional, sub-regional, and country level data includes the demand and supply forces along with their influence on the market.
• The competitive landscape comprises share of key players, new developments, and strategies in the last three years.
• Comprehensive companies offering products, relevant financial information, recent developments, SWOT analysis, and strategies by these players.